About this Research Topic
Renal diseases present significant global challenges, affecting millions and often necessitating complex pharmacological management. Despite advances in understanding renal pathophysiology and developing therapies, there remain gaps in translating research into effective clinical practice. Acknowledging this, "Reviews in Renal Pharmacology: 2024" aims to bridge these gaps by providing a platform for in-depth discussion of crucial topics and recent advancements in renal pharmacology.
"Reviews in Renal Pharmacology" is a new collection of high-quality scholarly review papers focusing on key topics and recent progress in the field. This Research Topic is designed to highlight important directions and new possibilities for future research while fostering discussion within the renal pharmacology community. By showcasing the latest developments, we aim to inspire best practices in clinical, public health, and policy settings.
We welcome submissions of full-length, mini, or systematic review papers that cover a broad spectrum of topics, including but not limited to:
• Pharmacological interventions to mitigate drug-induced nephrotoxicity, exploring renal injury mechanisms, renoprotection strategies, and novel therapeutic targets to preserve renal function.
• Innovative drug delivery systems tailored for renal therapeutics, such as nanotechnology, liposomal formulations, hydrogels, and polymer-based carriers designed to enhance drug efficacy and minimize adverse effects.
• Precision medicine approaches in renal pharmacotherapy, examining the interplay between genetic variations, individual patient characteristics, and drug response profiles.
• The use of AI and/or omics (including spatial transcriptomics) in renal drug discovery and pharmacology.
We also welcome articles highlighting emerging trends, new technologies, and innovative approaches to renal pharmacology.
"Reviews in Renal Pharmacology" is a new collection of high-quality scholarly review papers focusing on key topics and recent progress in the field. This Research Topic is designed to highlight important directions and new possibilities for future research while fostering discussion within the renal pharmacology community. By showcasing the latest developments, we aim to inspire best practices in clinical, public health, and policy settings.
We welcome submissions of full-length, mini, or systematic review papers that cover a broad spectrum of topics, including but not limited to:
• Pharmacological interventions to mitigate drug-induced nephrotoxicity, exploring renal injury mechanisms, renoprotection strategies, and novel therapeutic targets to preserve renal function.
• Innovative drug delivery systems tailored for renal therapeutics, such as nanotechnology, liposomal formulations, hydrogels, and polymer-based carriers designed to enhance drug efficacy and minimize adverse effects.
• Precision medicine approaches in renal pharmacotherapy, examining the interplay between genetic variations, individual patient characteristics, and drug response profiles.
• The use of AI and/or omics (including spatial transcriptomics) in renal drug discovery and pharmacology.
We also welcome articles highlighting emerging trends, new technologies, and innovative approaches to renal pharmacology.
Keywords: renal pharmacology, reviews, nephrotoxicity, renal injury, renoprotection, drug delivery, renal pharmacotherapy, drug discovery
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
